Nocopi (NNUP) 10-K 11 Sep 15 2014 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2014	Aug. 15, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	NOCOPI TECHNOLOGIES INC/MD/
Entity Central Index Key	888,981
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Type	10-K
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2,014
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Public Float			$ 1,037,000
Entity Common Stock Shares Outstanding		58,599,016
Entity Well Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current assets
Cash	$ 28,000	$ 52,900	$ 20,600	$ 22,900
Accounts receivable less $5,000 allowance for doubtful accounts	287,800	237,100	68,500
Inventory	43,500	28,500	26,000
Prepaid and other	18,800	31,500	23,800
Total current assets	378,100	350,000	138,900
Fixed assets
Leasehold improvements	19,700	72,500	72,500
Furniture, fixtures and equipment	176,800	186,300	184,500
Fixed assets, gross	196,500	258,800	257,000
Less: accumulated depreciation and amortization	178,400	257,300	256,400
Total fixed assets	18,100	1,500	600
Total assets	$ 396,200	351,500	139,500
Current liabilities
Promissory note		18,800	43,800
Demand loans	$ 63,000	$ 92,500	$ 89,500
Convertible debentures	102,900
Accounts payable	160,300	$ 169,500	$ 245,600
Accrued expenses	383,000	306,000	201,200
Deferred revenue	93,400	113,800	26,000
Total current liabilities	$ 802,600	$ 700,600	$ 606,100
Commitments and contingencies
Convertible debentures, net of unaccreted discount of $1,400 at December 31, 2014 and $6,300 at December 31, 2013	$ 31,800	$ 98,700
Stockholders' deficiency
Series A preferred stock, $1.00 par value, Authorized - 300,000 shares, Issued and outstanding - none
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,599,016 shares	$ 586,000	$ 586,000	$ 586,000
Paid-in capital	12,408,500	12,406,600	12,398,100
Accumulated deficit	(13,432,700)	(13,440,400)	(13,450,700)
Total stockholders' deficiency	(438,200)	(447,800)	(466,600)	$ (334,400)
Total liabilities and stockholders' deficiency	$ 396,200	$ 351,500	$ 139,500

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5,000	$ 5,000	$ 5,000
Unaccreted discount on convertible debentures	$ 1,400	$ 6,300
Preferred stock, par value	$ 1	$ 1	$ 1
Preferred stock, shares authorized	300,000	300,000	300,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, par value	$ 0.01	$ 0.01	$ 0.01
Common stock, shares authorized	75,000,000	75,000,000	75,000,000
Common stock, shares issued	58,599,016	58,599,016	58,599,016
Common stock, shares outstanding	58,599,016	58,599,016	58,599,016

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues
Licenses, royalties and fees	$ 358,800	$ 295,100	$ 414,900
Product and other sales	564,000	455,100	222,100
Total revenues	922,800	750,200	637,000
Cost of revenues
Licenses, royalties and fees	75,600	67,200	52,500
Product and other sales	248,700	218,300	149,500
Total cost of revenues	324,300	285,500	202,000
Gross profit	598,500	464,700	435,000
Operating expenses
Research and development	121,600	111,900	109,400
Sales and marketing	194,500	170,500	167,400
General and administrative	253,400	195,200	302,000
Total operating expenses	569,500	477,600	578,800
Net income (loss) from operations	$ 29,000	(12,900)	(143,800)
Other income (expenses)
Reversal of accounts payable		$ 39,500	$ 7,800
Interest income	$ 300
Interest expense, bank charges, financing cost and accretion of interest	(21,600)	$ (16,300)	$ (10,100)
Total other income (expenses)	(21,300)	23,200	(2,300)
Net income (loss)	$ 7,700	$ 10,300	$ (146,100)
Net income (loss) per common share
Basic	$ 0	$ 0	$ 0
Diluted	$ 0	$ 0	$ 0
Weighted average common shares outstanding
Basic	58,599,016	58,599,016	58,565,605
Diluted	58,600,690	58,687,694	58,565,605

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Common stock [Member]	Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2011	$ 583,500	$ 12,386,700	$ (13,304,600)	$ (334,400)
Balance (in shares) at Dec. 31, 2011	58,346,466
Sales of common stock, value	$ 2,100	7,900		10,000
Sales of common stock, shares	208,334
Conversion of demand notes and interest, value	$ 400	2,300		2,700
Conversion of demand notes and interest, shares	44,216
Fair value of warrants issued to demand loan holders		1,200		1,200
Net income (loss)			(146,100)	(146,100)
Balance at Dec. 31, 2012	$ 586,000	12,398,100	(13,450,700)	$ (466,600)
Balance (in shares) at Dec. 31, 2012	58,599,016			58,599,016
Fair value of warrants issued to demand loan holders		100		$ 100
Fair value of warrants issued to convertible debenture holders		8,400		8,400
Net income (loss)			10,300	10,300
Balance at Dec. 31, 2013	$ 586,000	12,406,600	(13,440,400)	$ (447,800)
Balance (in shares) at Dec. 31, 2013	58,599,016			58,599,016
Fair value of warrants issued to convertible debenture holders		1,900		$ 1,900
Net income (loss)			7,700	7,700
Balance at Dec. 31, 2014	$ 586,000	$ 12,408,500	$ (13,432,700)	$ (438,200)
Balance (in shares) at Dec. 31, 2014	58,599,016			58,599,016

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating Activities
Net income (loss)	$ 7,700	$ 10,300	$ (146,100)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization	$ 4,000	900	3,100
Reversal of accounts payable		(39,500)	(7,800)
Financing cost - warrant grants		100	$ 1,200
Accretion of interest - convertible debentures	$ 4,600	2,100
Net income (loss) adjusted for non-cash operating activities	16,300	(26,100)	$ (149,600)
(Increase) decrease in assets
Accounts receivable	(50,700)	(168,600)	(36,700)
Inventory	(15,000)	(2,500)	(5,200)
Prepaid and other	12,700	(7,700)	(500)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	71,600	68,200	174,500
Deferred revenue	(20,400)	87,800	(16,800)
Total increase (decrease) in operating capital	(1,800)	(22,800)	115,300
Net cash provided by (used in) operating activities	14,500	(48,900)	$ (34,300)
Investing Activities
Additions to fixed assets	(20,600)	(1,800)
Net cash used in investing activities	(20,600)	(1,800)
Financing Activities
Repayment of borrowings under promissory note	$ (18,800)	(25,000)	$ (25,000)
Proceeds from demand loans		$ 3,000	49,500
Repayment of demand loans	$ (5,000)		$ (2,500)
Proceeds from convertible debentures	$ 5,000	$ 105,000
Issuance of common stock			$ 10,000
Net cash provided by (used in) financing activities	$ (18,800)	$ 83,000	32,000
Increase (decrease) in cash	(24,900)	32,300	(2,300)
Cash
Beginning of year	52,900	20,600	22,900
End of year	28,000	52,900	20,600
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	300	$ 1,200	$ 2,200
Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment
Accumulated depreciation and amortization	(82,900)
Leasehold improvements	72,500
Furniture, fixtures and equipment	10,400
Conversion of demand loans and interest to convertible debentures
Demand loans	24,500
Accrued expenses	3,800
Convertible debentures	26,400
Paid-in capital	$ 1,900
Conversion of demand loans and interest to common stock
Demand loans			$ 1,500
Accrued expenses			1,200
Common stock			400
Paid-in capital			$ 2,300

Organization of the Company

Organization of the Company	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization of the Company	1. Organization of the Company Nocopi Technologies, Inc. (the “Company”) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. The Company operates in one principal industry segment.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Financial Statement Presentation - Estimates Cash Accounts receivable and credit policies The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected. Inventory Fixed assets Patent costs Revenues , Income taxes Fair value Earnings (loss) per share The table below presents the computation of basic and diluted weighted average common shares outstanding: 2014 2013 2012 Basic shares outstanding 58,599,016 58,599,016 58,565,605 Incremental shares from assumed conversion of stock options and warrants 1,674 88,678 – Diluted shares outstanding 58,600,690 58,687,694 58,565,605 Comprehensive income (loss) Recoverability of Long-Lived Assets The Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company’s annual financial statements. Recently Adopted Accounting Pronouncements As of December 31, 2014 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
Going Concern	3. Going Concern Since its inception, with the exception of the years ended December 31, 2007 and December 31, 2013 and December 13, 2014, during which it generated net income of $386,000 and $10,300 and $7,700, respectively, the Company has incurred significant losses and, as of December 31, 2014, had accumulated losses of $13,432,700. For the year ended December 31, 2014, the Company had net income from operations of $29,000. For the years ended December 31, 2013 and December 31, 2012, the Company’s had a net loss from operations of $12,900 and $143,800, respectively. The Company had negative working capital of $424,500 at December 31, 2014, $350,600 at December 31, 2013 and $467,200 at December 31, 2012. Due in part to uncertainties in the US economy, the Company, which is substantially dependent on its licensees to generate licensing revenues, may incur further operating losses and experience negative cash flow in the future. Achieving profitability and positive cash flow depends on the Company’s ability to generate and sustain significant increases in revenues and gross profits from its traditional business. There can be no assurances that the Company will be able to generate sufficient revenues and gross profits to sustain profitability and return to positive cash flow in the future. During 2014, the Company sold a $5,000 convertible debenture to an investor. During 2013, the Company sold convertible debentures totaling $105,000 to six individuals and a trust and received an unsecured loan of $3,000 from an individual. During 2012, the Company received unsecured loans totaling $49,500 from two individuals and repaid $2,500 of these loans during 2012. In 2012, the Company raised $10,000 in a private placement exempt from registration under section 4(2) of the Securities Act of 1933, as amended, whereby 208,334 shares of the Company’s common stock were sold to two non-affiliated individual investors. Receipt of funds from these investors and from the demand loan holders have allowed the Company to remain in operation through the current date. Management of the Company believes that it may need additional capital in the future both to fund investments needed to increase its operating revenues to levels that will sustain its operations and to fund operating deficits that it anticipates will continue until revenue increases from traditional and new product lines can be realized. There can be no assurances that the Company will be successful in obtaining sufficient additional capital, or if it does, that the additional capital will enable the Company to impact its revenues so as to have a material positive effect on the Company’s operations and cash flow. The Company believes that without additional capital, whether in the form of debt, equity or both, it may be forced to cease operations at an undetermined future date. The Company’s independent registered public accountants have included a “going concern” explanatory paragraph in their audit report accompanying the 2014 financial statements. The paragraph states that the Company’s continuing working capital deficit raises substantial doubt about the Company’s ability to continue as a going concern and cautions that the financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Concentration of Credit Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	4 Concentration of Credit Risk Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash and accounts receivables. At December 31, 2014, the Company did not have deposits with a financial institution that exceed the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.

Demand Loans

Demand Loans	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Demand Loans	5. Demand Loans In April 2012, the Company received an unsecured loan of $2,500 from an individual and repaid the loan, with interest at 8%, in May 2012. In July 2012, the Company received an unsecured loan of $5,800 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 5,800 shares of common stock of the Company at $0.06 per share to this individual. The warrants expire in five years. A financing cost of approximately $200, representing the fair value of the warrants, was charged to income in the third quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.64%; expected volatility based on the Company’s historical volatility-108%; and dividend yield-0. In July 2012, the Company received an unsecured loan of $3,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 3,000 shares of common stock of the Company at $0.06 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the third quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.60%; expected volatility based on the Company’s historical volatility-108%; and dividend yield-0. In August 2012, the Company received an unsecured loan of $3,500 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 3,500 shares of common stock of the Company at $0.07 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the third quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.61%; expected volatility based on the Company’s historical volatility-108%; and dividend yield-0. In September 2012, the Company received an unsecured loan of $20,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 20,000 shares of common stock of the Company at $0.03 per share to this individual. The warrants expire in five years. A financing cost of approximately $400, representing the fair value of the warrants, was charged to income in the third quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.68%; expected volatility based on the Company’s historical volatility-110%; and dividend yield-0. In October 2012, the Company received an unsecured loan of $3,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 3,000 shares of common stock of the Company at $0.03 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the fourth quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.67%; expected volatility based on the Company’s historical volatility-113%; and dividend yield-0. In October 2012, the Company received an unsecured loan of $3,700 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 3,700 shares of common stock of the Company at $0.025 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the fourth quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.67%; expected volatility based on the Company’s historical volatility-113%; and dividend yield-0. In October 2012, the Company received an unsecured loan of $4,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 4,000 shares of common stock of the Company at $0.022 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the fourth quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.82%; expected volatility based on the Company’s historical volatility-113%; and dividend yield-0. In November 2012, the Company received an unsecured loan of $4,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 4,000 shares of common stock of the Company at $0.01 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the fourth quarter of 2012. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.73%; expected volatility based on the Company’s historical volatility-113%; and dividend yield-0. In March 2013, the Company received an unsecured loan of $3,000 from an individual. The loan bears interest at 8% and is payable on demand. The loan was used to finance the Company’s working capital requirements. Additionally, the Company granted warrants to purchase 3,000 shares of common stock of the Company at $0.021 per share to this individual. The warrants expire in five years. A financing cost of approximately $100, representing the fair value of the warrants, was charged to income in the first quarter of 2013. The fair value of the warrants was determined using the Black-Scholes pricing model with the following assumptions: expected life-5 years; interest rate-.77%; expected volatility based on the Company’s historical volatility-101%; and dividend yield-0.

Promissory Note

Promissory Note	12 Months Ended
	Dec. 31, 2014
Line of Credit Facility [Abstract]
Promissory Note	6. Promissory Note In 2008, the Company negotiated a $100,000 revolving line of credit with a bank to provide a source of working capital. The line of credit was secured by all the assets of the Company and bore interest at the bank’s prime rate plus 0.5%. During the term of the line of credit, the interest rate applicable to the Company’s line of credit was 3.75%. During the year ended December 31, 2009, the Company borrowed the entire $100,000 available under the line of credit. Until the third quarter of 2010, the Company had been required to pay interest only on borrowings under the line of credit. During the third quarter of 2010, the Company was notified by the bank that the line of credit was not being renewed and was offered repayment terms, which the Company accepted, to repay the outstanding loan balance in forty-eight equal monthly installments of $2,083, plus interest at the bank’s prime rate plus 0.5%, which was 3.75% throughout the repayment term, beginning in October 2010. In early July 2014, the Company repaid $6,250, the then remaining outstanding balance of the note.

Convertible Debentures

Convertible Debentures	12 Months Ended
	Dec. 31, 2014
Convertible Debt [Abstract]
Convertible Debentures	7. Convertible Debentures During the third quarter of 2013, the Company received $105,000 through the issuance of convertible debentures to six individual investors and a trust. The debentures bear interest at 7% and are due and payable two years from the date of issuance. Proceeds of the debenture issuance were used to finance the Company’s working capital requirements. At option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 525,000 shares of the Company’s common stock at $0.02 per share to the holders of the debentures. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants of approximately $9,100 was determined using the Black-Scholes pricing model. The relative fair value of the warrants was approximately $8,300 and was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances is being accreted through interest expense over the term of the notes payable. For the years ended December 31, 2014 and 2013, approximately $4,200 and $2,100, respectively, was accreted through interest expense. During the third quarter of 2014, the Company, with the approval of its Board of Directors, exchanged two demand loans totaling $24,500 including one demand loan in the amount of $4,500 held by Herman M. Gerwitz, a Director, along with approximately $3,800 of accrued interest for convertible debentures totaling approximately $28,300. The debentures bear interest at 7% and are due and payable two years from the date of issuance. At option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase approximately 141,400 shares of common stock of the Company at $0.02 per share to the debenture holders. The warrants are exercisable two years after issuance and expire seven years after issuance. During the third quarter of 2014, the Company received $5,000 through the issuance of a convertible debenture to an investor. The debenture bears interest at 7% and is due and payable two years from the date of issuance. At option of the lender, the debenture and accrued interest are convertible in whole or part into common stock of the Company at $0.05 per share. The Company also granted warrants to purchase 25,000 shares of the Company’s common stock at $0.02 per share to the holder of the debenture. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the approximately 166,400 warrants issued in the third quarter of 2014 of approximately $2,000 was determined using the Black-Scholes pricing model. The relative fair value of the warrants was approximately $1,900 and was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances is being accreted through interest expense over the term of the notes payable. For the year ended December 31, 2014, approximately $500 was accreted through interest expense.

Stockholders' Deficiency

Stockholders' Deficiency	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Deficiency	8. Stockholders' Deficiency During 2012, the Company sold 208,334 shares of its common stock to a non-affiliated investor for $10,000 pursuant to a private placement. The Company, with the approval of its Board of Directors, entered into a Conversion Agreement effective March 16, 2012 with Herman M. Gerwitz, a Director, whereby $1,500 in principal of the unsecured loan owed by the Company to him, together with approximately $1,200 of accrued interest was converted into 44,216 shares of restricted common stock of the Company at $0.06 per share, the market price at the date of conversion. After giving effect to this conversion, the principal balance of the unsecured loan held by Mr. Gerwitz was reduced to $4,500. In July 2014, the common stock private placement was extended to December 31, 2015 by the Company’s Board of Directors.

Other Income (Expenses)

Other Income (Expenses)	12 Months Ended
	Dec. 31, 2014
Other Income and Expenses [Abstract]
Other Income (Expenses)	9. Other Income (Expenses) Other income (expenses) includes, in 2013, the reversal of approximately $39,500 of accounts payable related to invoices received during 2009 from a professional services business that provided consulting services to the Company that the Company, with legal counsel, has determined to be no longer statutorily payable as the statute of limitations to bring a claim has expired and, in 2012 ,

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes There is no provision for income taxes for the years ended December 31, 2014 and 2013 due to the availability of net operating loss carryforwards. There is no income tax benefit for the year ended December 31, 2012 due to the availability of net operating loss carryforwards (“NOL’s”) for which the Company had previously established a 100% valuation allowance for deferred tax assets due to the uncertainty of their recoverability. At December 31, 2014, December 31, 2013 and December 31, 2012, the Company had NOL’s approximating $4,601,000, $5,079,000 and $5,658,000, respectively. The operating losses at December 31, 2014 are available to offset future taxable income; however, if not utilized, they expire in varying amounts through the year 2034. As a result of the sale of the Company's common stock in an equity offering in late 1997 and the issuance of additional shares, the amount of the NOL’s may be limited. Additionally, the utilization of these NOL’s, if available, to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December 31, 2014, December 31, 2013 and December 31, 2012. The Company has established a 100% valuation allowance of approximately $1,933,000, $2,133,000 and $2,377,000 at December 31, 2014, December 31, 2013 and December 31, 2012, respectively, for the deferred tax assets due to the uncertainty of their realization. The Company has adopted the provisions of FASB ASC 740-10-50-15, “Unrecognized Tax Benefit Related Disclosures.” There were no unrecognized tax benefits as of the date of adoption and no unrecognized tax benefits at December 31, 2014. There was no change in unrecognized tax benefits during the year ended December 31, 2014 and there was no accrual for uncertain tax positions as of December 31, 2014. There were no interest and penalties recognized in the statement of operations and in the balance sheet. Tax years from 2011 through 2014 remain subject to examination by U.S. federal and state tax jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2019. Future minimum lease payments under non-cancelable operating leases with initial or remaining terms of one year or more at December 31, 2014 are: $44,900 – 2015; $46,200 – 2016; $47,400 –2017; $48,600 – 2018 and $16,300 – 2019. Total rental expense under operating leases was $44,400, $44,200 and $44,800 in 2012, 2013 and 2014 respectively. The Company has an employment agreement, expiring in May 2016, with Michael A. Feinstein, M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that become effective after the original term. Dr. Feinstein receives base compensation of $85,000 per year plus a performance bonus determined by the Company’s Board of Directors. The Company has an employment agreement, expiring in March 2016, with Terry W. Stovold, its Chief Operating Officer, whereby Mr. Stovold receives a salary set by the Company’s Board of Directors, currently set at $75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that become effective after the original term. Future minimum compensation payments under these employment agreements are: $160,000 to be paid in 2015 and $54,200 to be paid in 2016. From time to time, the Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.

Stock Options, Warrants and 401

Stock Options, Warrants and 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options, Warrants and 401(k) Savings Plan	12. Stock Options, Warrants and 401(k) Savings Plan The Company follows FASB ASC 718, Share Based Payment, The 1999 Stock Option Plan provided for the granting of up to 2,000,000 incentive and non-qualified stock options to employees, non-employee directors, consultants and advisors to the Company. In the case of options designated as incentive stock options, the exercise price of the options granted must be not less than the fair market value of such shares on the date of grant. Non-qualified stock options may be granted at any amount established by the Stock Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The 1999 Stock Option Plan terminated in February 2009 and no further stock options can be granted under the plan; however, options granted before the termination date may be exercised through their expiration date. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December 31, 2014, 2013 and 2012 and there was no unrecognized portion of expense at December 31, 2014. A summary of stock options under the Company’s stock option plans follows: Weighted Exercise Average Number of Price Range Exercise Shares Per Share Price Outstanding at December 31, 2011 and 2012 645,000 $0.12 and $.45 $0.32 Options expired 400,000 0.45 0.45 Outstanding at December 31, 2013 245,000 0.12 0.12 Options expired 245,000 0.12 0.12 Outstanding at December 31, 2014 0 – – Option Shares Exercisable options at year end: 2014 0 Weighted average remaining contractual life (years) – Options available for future grant: 2014 0 At December 31, 2014, the Company had 802,365 warrants to purchase common stock of the Company outstanding at exercise prices ranging from $0.01 to $0.07 and expiring at various dates through July 2021. The warrants were granted from 2010 to 2013 to six individuals in conjunction with loans provided to the Company, to ten investors who acquired convertible debentures from the Company in 2013 and 2014 and, in 2011, to a professional services provider related to certain fee payment considerations granted by the individual. A summary of outstanding warrants follows: Weighted Exercise Average Number of Price Range Exercise Shares Per Share Price Outstanding at December 31, 2011 85,500 $0.045 to $0.07 $0.061 Warrants granted 47,000 0.01 to 0.07 0.036 Outstanding at December 31, 2012 132,500 0.01 to 0.07 0.052 Warrants granted 528,000 0.02 and 0.021 0.02 Outstanding at December 31, 2013 660,500 0.01 to 0.07 0.026 Warrants granted 166,365 0.02 0.02 Warrants canceled 24,500 0.03 and 0.07 0.037 Outstanding at December 31, 2014 802,365 $0.01 to $0.07 $0.025 Weighted average remaining contractual life (years) 5.21 Weighted Exercise Average Price Range Exercise Shares Per Share Price Exercisable warrants at year end: 2014 111,000 $0.01 to $0.07 $0.055 Weighted average remaining contractual life (years) 1.33 At December 31, 2014, the Company has reserved 3,955,005 shares of common stock for possible future issuance upon exercise of 802,365 warrants and for the conversion of approximately $138,300 convertible debentures and accrued interest into 3,152,640 shares of common stock. The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of the Company. There were no contributions charged to expense during 2014, 2013 or 2012.

Major Customer and Geographic I

Major Customer and Geographic Information	12 Months Ended
	Dec. 31, 2014
Major Customer and Geographic Information [Abstract]
Major Customer and Geographic Information	13. Major Customer and Geographic Information The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were: Year ended December 31 2014 2013 2012 Customer A 47 % 49 % 14 % Customer B 19 % 15 % 10 % The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were: December 31 2014 2013 2012 Customer A 46 % 45 % 48 % Customer B 35 % 32 % 20 % The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company’s business operations and financial condition. The Company’s revenues by geographic region are as follows: Year ended December 31 2014 2013 2012 North America $ 477,100 $ 365,700 $ 540,600 Asia 445,700 384,500 96,400 $ 922,800 $ 750,200 $ 637,000

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Event	14. Subsequent Events Through July 2015, the Company repaid $26,000 of the principal of the outstanding demand loans. In July 2015, the Company repaid, with interest, a $10,000 convertible debenture that had matured. In July 2015, the Company’s Board of Directors extended the Common Stock private placement to December 31, 2016. During the third quarter of 2015, the Company’s Board of Directors approved and the holders of $95,000 of convertible debentures maturing during the third quarter of 2015 accepted an offer of extension whereby the maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of the Company is reduced from $0.05 to $0.025.

Quarterly Financial Information

Quarterly Financial Information (Unaudited)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information (Unaudited)	15. Quarterly Financial Information (Unaudited) Nocopi Technologies, Inc. Balance Sheets (Unaudited) September 30, June 30, March 31, 2014 2014 2014 Assets Current assets Cash $ 72,700 $ 9,300 $ 36,800 Accounts receivable less $5,000 allowance 185,300 265,500 198,200 Inventory 47,500 29,900 36,800 Prepaid and other 10,100 12,000 21,200 Total current assets 315,600 316,700 293,000 Fixed assets Leasehold improvements 19,100 19,100 19,100 Furniture, fixture and equipment 176,800 176,800 176,800 195,900 195,900 195,900 Less: accumulated depreciation and amortization 177,300 176,100 174,800 18,600 19,800 21,100 Total assets $ 334,200 $ 336,500 $ 314,100 Liabilities and Stockholders' Deficiency Current liabilities Promissory note $ – $ 6,300 $ 12,500 Demand loans 63,000 92,500 92,500 Convertible debentures 101,900 – – Accounts payable 135,200 130,400 147,200 Accrued expenses 362,800 348,600 329,500 Deferred revenue 123,100 120,800 105,700 Total current liabilities 786,000 698,600 687,400 Convertible debentures 31,600 100,800 99,700 Stockholders' deficiency Common stock, $0.01 par value, Authorized - 75,000,000 shares, Issued and outstanding - 58,599,016 shares 586,000 586,000 586,000 Paid-in capital 12,408,500 12,406,600 12,406,600 Accumulated deficit (13,477,900 ) (13,455,500 ) (13,465,600 ) (483,400 ) (462,900 ) (473,000 ) Total liabilities and stockholders deficiency $ 334,200 $ 336,500 $ 314,100 Nocopi Technologies, Inc. Balance Sheets (Unaudited) September 30, June 30, March 31, September 30, June 30, 2013 2013 2013 2012 2012 Assets Current assets Cash $ 117,600 $ 23,400 $ 1,100 $ 5,700 $ 8,400 Accounts receivable less $5,000 allowance 159,400 153,600 157,700 77,900 67,100 Inventory 29,000 52,200 10,300 21,800 15,100 Prepaid and other 11,400 13,800 17,100 12,500 17,500 Total current assets 317,400 243,000 186,200 117,900 108,100 Fixed assets Leasehold improvements 72,500 72,500 72,500 72,500 72,500 Furniture, fixture and equipment 184,500 184,500 184,500 184,500 184,500 257,000 257,000 257,000 257,000 257,000 Less: accumulated depreciation and amortization 257,000 257,000 256,700 256,000 255,100 – – 300 1,000 1,900 Total assets $ 317,400 $ 243,000 $ 186,500 $ 118,900 $ 110,000 Liabilities and Stockholders’ Deficiency Current liabilities Promissory note $ 25,000 $ 31,300 $ 37,500 $ 50,000 $ 56,300 Demand loans 92,500 92,500 92,500 74,800 42,500 Accounts payable 195,200 235,500 253,000 215,400 192,600 Accrued expenses 291,500 277,600 236,500 158,000 104,200 Deferred revenue 113,600 114,500 69,000 53,000 107,100 Total current liabilities 717,800 751,400 688,500 551,200 502,700 Convertible debentures 97,700 – – – – Stockholders’ deficiency Common stock, $0.01 par value, Authorized - 75,000,000 shares, Issued and outstanding - 58,599,016 shares 586,000 586,000 586,000 586,000 586,000 Paid-in capital 12,406,600 12,398,200 12,398,200 12,397,900 12,396,900 Accumulated deficit (13,490,700 ) (13,492,600 ) (13,486,200 ) (13,416,200 ) (13,375,600 ) (498,100 ) (508,400 ) (502,000 ) (432,300 ) (392,700 ) Total liabilities and stockholders’ deficiency $ 317,400 $ 243,000 $ 186,500 $ 118,900 $ 110,000 Nocopi Technologies, Inc. Statements of Operations (Unaudited) Three Months Nine Months Three Months Six Months Three Months ended ended ended ended ended September 30, September 30, June 30, June 30, March 31, 2014 2014 2014 2014 2014 Revenues Licenses, royalties and fees $ 83,000 $ 240,500 $ 77,500 $ 157,500 $ 80,000 Product and other sales 125,800 389,300 158,600 263,500 104,900 208,800 629,800 236,100 421,000 184,900 Cost of revenues Licenses, royalties and fees 17,700 54,200 19,300 36,500 17,200 Product and other sales 56,000 176,500 65,200 120,500 55,300 73,700 230,700 84,500 157,000 72,500 Gross profit 135,100 399,100 151,600 264,000 112,400 Operating expenses Research and development 29,200 90,200 30,400 61,000 30,600 Sales and marketing 46,800 141,000 46,600 94,200 47,600 General and administrative 75,900 189,500 59,200 113,600 54,400 151,900 420,700 136,200 268,800 132,600 Net income (loss) from operations (16,800 ) (21,600 ) 15,400 (4,800 ) (20,200 ) Other income (expenses) Reversal of accounts payable Interest income – 300 – 300 300 Interest expense, bank charges and accretion of interest (5,600 ) (16,200 ) (5,300 ) (10,600 ) (5,300 ) (5,600 ) (15,900 ) (5,300 ) (10,300 ) (5,000 ) Net loss $ (22,400 ) $ (37,500 ) $ 10,100 $ (15,100 ) $ (25,200 ) Basic and diluted loss per common share $ (.00 ) $ (.00 ) $ .00 $ (.00 ) $ (.00 ) Weighted average common shares outstanding Basic 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 Diluted 58,599,016 58,599,016 58,600,830 58,599,016 58,599,016 Nocopi Technologies, Inc. Statements of Operations (Unaudited) Three Months Nine Months Three Months Six Months Three Months Three Months Nine Months Three Months Six Months ended ended ended ended ended ended ended ended ended September 30, September 30, June 30, June 30, March 31, September 30, September 30, June 30, June 30, 2013 2013 2013 2013 2013 2012 2012 2012 2012 Revenues Licenses, royalties and fees $ 82,800 $ 209,800 $ 69,900 $ 127,000 $ 57,100 $ 107,700 $ 324,600 $ 112,800 $ 216,900 Product and other sales 106,900 307,200 116,400 200,300 83,900 23,800 172,400 85,200 148,600 189,700 517,000 186,300 327,300 141,000 131,500 497,000 198,000 365,500 Cost of revenues Licenses, royalties and fees 15,100 46,600 17,400 31,500 14,100 10,400 40,200 14,400 29,800 Product and other sales 50,400 148,500 56,200 98,100 41,900 27,000 117,600 43,200 90,600 65,500 195,100 73,600 129,600 56,000 37,400 157,800 57,600 120,400 Gross profit 124,200 321,900 112,700 197,700 85,000 94,100 339,200 140,400 245,100 Operating expenses Research and development 27,800 82,900 26,600 55,100 28,500 26,200 82,000 27,700 55,800 Sales and marketing 43,400 123,800 41,100 80,400 39,300 38,100 129,800 45,500 91,700 General and administrative 46,300 144,500 48,400 98,200 49,800 67,100 240,000 71,300 172,900 117,500 351,200 116,100 233,700 117,600 131,400 451,800 144,500 320,400 Net income (loss) from operations 6,700 (29,300 ) (3,400 ) (36,000 ) (32,600 ) (37,300 ) (112,600 ) (4,100 ) (75,300 ) Other income (expenses) Reversal of accounts payable – – – – – – 7,800 2,200 7,800 Interest expense, bank charges, financing cost and accretion of interest (4,800 ) (10,700 ) (3,000 ) (5,900 ) (2,900 ) (3,300 ) (6,800 ) (1,800 ) (3,500 ) (4,800 ) (10,700 ) (3,000 ) (5,900 ) (2,900 ) (3,300 ) 1,000 400 4,300 Net income (loss) $ 1,900 $ (40,000 ) $ (6,400 ) $ (41,900 ) $ (35,500 ) $ (40,600 ) $ (111,600 ) $ (3,700 ) $ (71,000 ) Net income (loss) per common share Basic $ .00 $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) Diluted $ .00 $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) Weighted average common shares outstanding Basic 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,554,194 58,599,016 58,532,194 Diluted 58,745,139 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,554,194 58,599,016 58,532,194 Nocopi Technologies, Inc. Statements of Cash Flows (Unaudited) Nine Months Six Months Three Months ended ended ended September 30, June 30, March 31, 2014 2014 2014 Operating Activities Net loss $ (37,500 ) $ (15,100 ) $ (25,200 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities Depreciation and amortization 2,900 1,700 400 Accretion of interest - convertible debentures 3,400 2,100 1,000 (31,200 ) (11,300 ) (23,800 ) (Increase) decrease in assets Accounts receivable 51,800 (28,400 ) 38,900 Inventory (19,000 ) (1,400 ) (8,300 ) Prepaid and other 21,400 19,500 10,300 Increase (decrease) in liabilities Accounts payable and accrued expenses 26,300 3,500 1,200 Deferred revenue 9,300 7,000 (8,100 ) 89,800 200 34,000 Net cash provided by (used in) operating activities 58,600 (11,100 ) 10,200 Investment Activities Additions to fixed assets (20,000 ) (20,000 ) (20,000 ) Net cash used in investment activities (20,000 ) (20,000 ) (20,000 ) Financing Activities Repayment of borrowings under promissory note (18,800 ) (12,500 ) (6,300 ) Repayment of demand loans (5,000 ) – – Proceeds from convertible debenture 5,000 – – Net cash used in financing activities (18,800 ) (12,500 ) (6,300 ) 19,800 (43,600 ) (16,100 ) Cash at beginning of year 52,900 52,900 52,900 Cash at end of period 72,700 9,300 36,800 Supplemental Disclosure of Cash Flow Information Cash paid for interest $ 300 $ 300 $ 200 Supplemental Disclosure of Non Cash Investing Activities Write-off of fully depreciated leasehold improvements and furniture, fixtures and equipment Accumulated depreciation and amortization $ (82,900 ) $ (82,900 ) $ (82,900 ) Leasehold improvements $ 72,500 $ 72,500 $ 72,500 Furniture, fixtures and equipment $ 10,400 $ 10,400 $ 10,400 Supplemental Disclosure of Non Cash Financing Activities Conversion of demand loans and interest to convertible debentures Demand loans $ 24,500 – – Accrued expenses $ 3,800 – – Convertible debentures $ 26,400 – – Paid-in capital $ 1,900 – – Nocopi Technologies, Inc. Statements of Cash Flows (Unaudited) Nine Months Six Months Three Months Nine Months Six Months ended ended ended ended ended September 30, June 30, March 31, September 30, June 30, 2013 2013 2013 2012 2012 Operating Activities Net loss $ (40,000 ) $ (41,900 ) $ (35,500 ) $ (111,600 ) $ (71,000 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities Depreciation and amortization 600 600 300 2,700 1,800 Reversal of accounts payable – – – (7,800 ) (7,800 ) Financing cost – warrant grants 100 100 100 1,000 – Accretion of interest – convertible debentures 1,100 – – – – (38,200 ) (41,200 ) (35,100 ) (115,700 ) (77,000 ) (Increase) decrease in assets Accounts receivable (90,900 ) (85,100 ) (89,200 ) (46,100 ) (35,300 ) Inventory (3,000 ) (26,200 ) 15,700 (1,000 ) 5,700 Prepaid and other 12,400 10,000 6,700 10,800 5,800 Increase in liabilities Accounts payable and accrued expenses 39,900 66,300 42,700 101,100 24,500 Deferred revenue 87,600 88,500 43,000 10,200 64,300 46,000 53,500 18,900 75,000 65,000 Net cash provided by (used in) operating activities 7,800 12,300 (16,200 ) (40,700 ) (12,000 ) Financing Activities Repayment of borrowings under promissory note (18,800 ) (12,500 ) (6,300 ) (18,800 ) (12,500 ) Proceeds from demand loan 3,000 3,000 3,000 34,800 2,500 Repayment of demand loan – – – (2,500 ) (2,500 ) Proceeds from convertible debentures 105,000 – – – – Issuance of common stock – – – 10,000 10,000 Net cash provided by (used in) financing activities 89,200 (9,500 ) (3,300 ) 23,500 (2,500 ) Increase (decrease) in cash 97,000 2,800 (19,500 ) (17,200 ) (14,500 ) Cash at beginning of year 20,600 20,600 20,600 22,900 22,900 Cash at end of period $ 117,600 $ 23,400 $ 1,100 $ 5,700 $ 8,400 Supplemental Disclosure of Cash Flow Information Cash paid for interest $ 1,000 $ 700 $ 400 $ 1,700 $ 1,200 Supplemental disclosure of Non Cash Financing Activities Conversion of demand loan and interest to common stock Demand loans – – – $ 1,500 $ 1,500 Accrued expenses – – – $ 1,200 $ 1,200 Common stock – – – $ 400 $ 400 Paid-in capital – – – $ 2,300 $ 2,300

Significant Accounting Polici22

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Financial Statement Presentation	Financial Statement Presentation -
Estimates	Estimates
Cash	Cash
Accounts receivable and credit policies	Accounts receivable and credit policies The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.
Inventory	Inventory
Fixed assets	Fixed assets
Patent costs	Patent costs
Revenues	Revenues
Income taxes	Income taxes
Fair value	Fair value
Earnings (loss) per share	Earnings (loss) per share The table below presents the computation of basic and diluted weighted average common shares outstanding: 2014 2013 2012 Basic shares outstanding 58,599,016 58,599,016 58,565,605 Incremental shares from assumed conversion of stock options and warrants 1,674 88,678 – Diluted shares outstanding 58,600,690 58,687,694 58,565,605
Comprehensive income (loss)	Comprehensive income (loss)
Recoverability of Long-Lived Assets	Recoverability of Long-Lived Assets The Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to the Company’s annual financial statements.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements As of December 31, 2014 and for the year then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.

Significant Accounting Polici23

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Computation of Basic and Diluted Weighted Average Common Shares Outstanding	The table below presents the computation of basic and diluted weighted average common shares outstanding: 2014 2013 2012 Basic shares outstanding 58,599,016 58,599,016 58,565,605 Incremental shares from assumed conversion of stock options and warrants 1,674 88,678 – Diluted shares outstanding 58,600,690 58,687,694 58,565,605

Stock Options, Warrants and 424

Stock Options, Warrants and 401(k) Savings Plan (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock Option Activity	A summary of stock options under the Company’s stock option plans follows: Weighted Exercise Average Number of Price Range Exercise Shares Per Share Price Outstanding at December 31, 2011 and 2012 645,000 $0.12 and $.45 $0.32 Options expired 400,000 0.45 0.45 Outstanding at December 31, 2013 245,000 0.12 0.12 Options expired 245,000 0.12 0.12 Outstanding at December 31, 2014 0 – – Option Shares Exercisable options at year end: 2014 0 Weighted average remaining contractual life (years) – Options available for future grant: 2014 0
Schedule of Warrants Outstanding	A summary of outstanding warrants follows: Weighted Exercise Average Number of Price Range Exercise Shares Per Share Price Outstanding at December 31, 2011 85,500 $0.045 to $0.07 $0.061 Warrants granted 47,000 0.01 to 0.07 0.036 Outstanding at December 31, 2012 132,500 0.01 to 0.07 0.052 Warrants granted 528,000 0.02 and 0.021 0.02 Outstanding at December 31, 2013 660,500 0.01 to 0.07 0.026 Warrants granted 166,365 0.02 0.02 Warrants canceled 24,500 0.03 and 0.07 0.037 Outstanding at December 31, 2014 802,365 $0.01 to $0.07 $0.025 Weighted average remaining contractual life (years) 5.21 Weighted Exercise Average Price Range Exercise Shares Per Share Price Exercisable warrants at year end: 2014 111,000 $0.01 to $0.07 $0.055 Weighted average remaining contractual life (years) 1.33

Major Customer and Geographic25

Major Customer and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Revenues from Non-affiliated Customers	The Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company’s total revenues were: Year ended December 31 2014 2013 2012 Customer A 47 % 49 % 14 % Customer B 19 % 15 % 10 %
Schedule of Non-affiliated Customers with Accounts Receivable More Than 10%	The Company’s non-affiliate customers whose individual balances amounted to more than 10% of the Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were: December 31 2014 2013 2012 Customer A 46 % 45 % 48 % Customer B 35 % 32 % 20 %
Schedule of Revenue by Geographic Region	The Company’s revenues by geographic region are as follows: Year ended December 31 2014 2013 2012 North America $ 477,100 $ 365,700 $ 540,600 Asia 445,700 384,500 96,400 $ 922,800 $ 750,200 $ 637,000

Quarterly Financial Informati26

Quarterly Financial Information (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedules of Quarterly Information	Nocopi Technologies, Inc. Balance Sheets (Unaudited) September 30, June 30, March 31, 2014 2014 2014 Assets Current assets Cash $ 72,700 $ 9,300 $ 36,800 Accounts receivable less $5,000 allowance 185,300 265,500 198,200 Inventory 47,500 29,900 36,800 Prepaid and other 10,100 12,000 21,200 Total current assets 315,600 316,700 293,000 Fixed assets Leasehold improvements 19,100 19,100 19,100 Furniture, fixture and equipment 176,800 176,800 176,800 195,900 195,900 195,900 Less: accumulated depreciation and amortization 177,300 176,100 174,800 18,600 19,800 21,100 Total assets $ 334,200 $ 336,500 $ 314,100 Liabilities and Stockholders' Deficiency Current liabilities Promissory note $ – $ 6,300 $ 12,500 Demand loans 63,000 92,500 92,500 Convertible debentures 101,900 – – Accounts payable 135,200 130,400 147,200 Accrued expenses 362,800 348,600 329,500 Deferred revenue 123,100 120,800 105,700 Total current liabilities 786,000 698,600 687,400 Convertible debentures 31,600 100,800 99,700 Stockholders' deficiency Common stock, $0.01 par value, Authorized - 75,000,000 shares, Issued and outstanding - 58,599,016 shares 586,000 586,000 586,000 Paid-in capital 12,408,500 12,406,600 12,406,600 Accumulated deficit (13,477,900 ) (13,455,500 ) (13,465,600 ) (483,400 ) (462,900 ) (473,000 ) Total liabilities and stockholders deficiency $ 334,200 $ 336,500 $ 314,100 Nocopi Technologies, Inc. Balance Sheets (Unaudited) September 30, June 30, March 31, September 30, June 30, 2013 2013 2013 2012 2012 Assets Current assets Cash $ 117,600 $ 23,400 $ 1,100 $ 5,700 $ 8,400 Accounts receivable less $5,000 allowance 159,400 153,600 157,700 77,900 67,100 Inventory 29,000 52,200 10,300 21,800 15,100 Prepaid and other 11,400 13,800 17,100 12,500 17,500 Total current assets 317,400 243,000 186,200 117,900 108,100 Fixed assets Leasehold improvements 72,500 72,500 72,500 72,500 72,500 Furniture, fixture and equipment 184,500 184,500 184,500 184,500 184,500 257,000 257,000 257,000 257,000 257,000 Less: accumulated depreciation and amortization 257,000 257,000 256,700 256,000 255,100 – – 300 1,000 1,900 Total assets $ 317,400 $ 243,000 $ 186,500 $ 118,900 $ 110,000 Liabilities and Stockholders’ Deficiency Current liabilities Promissory note $ 25,000 $ 31,300 $ 37,500 $ 50,000 $ 56,300 Demand loans 92,500 92,500 92,500 74,800 42,500 Accounts payable 195,200 235,500 253,000 215,400 192,600 Accrued expenses 291,500 277,600 236,500 158,000 104,200 Deferred revenue 113,600 114,500 69,000 53,000 107,100 Total current liabilities 717,800 751,400 688,500 551,200 502,700 Convertible debentures 97,700 – – – – Stockholders’ deficiency Common stock, $0.01 par value, Authorized - 75,000,000 shares, Issued and outstanding - 58,599,016 shares 586,000 586,000 586,000 586,000 586,000 Paid-in capital 12,406,600 12,398,200 12,398,200 12,397,900 12,396,900 Accumulated deficit (13,490,700 ) (13,492,600 ) (13,486,200 ) (13,416,200 ) (13,375,600 ) (498,100 ) (508,400 ) (502,000 ) (432,300 ) (392,700 ) Total liabilities and stockholders’ deficiency $ 317,400 $ 243,000 $ 186,500 $ 118,900 $ 110,000 Nocopi Technologies, Inc. Statements of Operations (Unaudited) Three Months Nine Months Three Months Six Months Three Months ended ended ended ended ended September 30, September 30, June 30, June 30, March 31, 2014 2014 2014 2014 2014 Revenues Licenses, royalties and fees $ 83,000 $ 240,500 $ 77,500 $ 157,500 $ 80,000 Product and other sales 125,800 389,300 158,600 263,500 104,900 208,800 629,800 236,100 421,000 184,900 Cost of revenues Licenses, royalties and fees 17,700 54,200 19,300 36,500 17,200 Product and other sales 56,000 176,500 65,200 120,500 55,300 73,700 230,700 84,500 157,000 72,500 Gross profit 135,100 399,100 151,600 264,000 112,400 Operating expenses Research and development 29,200 90,200 30,400 61,000 30,600 Sales and marketing 46,800 141,000 46,600 94,200 47,600 General and administrative 75,900 189,500 59,200 113,600 54,400 151,900 420,700 136,200 268,800 132,600 Net income (loss) from operations (16,800 ) (21,600 ) 15,400 (4,800 ) (20,200 ) Other income (expenses) Reversal of accounts payable Interest income – 300 – 300 300 Interest expense, bank charges and accretion of interest (5,600 ) (16,200 ) (5,300 ) (10,600 ) (5,300 ) (5,600 ) (15,900 ) (5,300 ) (10,300 ) (5,000 ) Net loss $ (22,400 ) $ (37,500 ) $ 10,100 $ (15,100 ) $ (25,200 ) Basic and diluted loss per common share $ (.00 ) $ (.00 ) $ .00 $ (.00 ) $ (.00 ) Weighted average common shares outstanding Basic 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 Diluted 58,599,016 58,599,016 58,600,830 58,599,016 58,599,016 Nocopi Technologies, Inc. Statements of Operations (Unaudited) Three Months Nine Months Three Months Six Months Three Months Three Months Nine Months Three Months Six Months ended ended ended ended ended ended ended ended ended September 30, September 30, June 30, June 30, March 31, September 30, September 30, June 30, June 30, 2013 2013 2013 2013 2013 2012 2012 2012 2012 Revenues Licenses, royalties and fees $ 82,800 $ 209,800 $ 69,900 $ 127,000 $ 57,100 $ 107,700 $ 324,600 $ 112,800 $ 216,900 Product and other sales 106,900 307,200 116,400 200,300 83,900 23,800 172,400 85,200 148,600 189,700 517,000 186,300 327,300 141,000 131,500 497,000 198,000 365,500 Cost of revenues Licenses, royalties and fees 15,100 46,600 17,400 31,500 14,100 10,400 40,200 14,400 29,800 Product and other sales 50,400 148,500 56,200 98,100 41,900 27,000 117,600 43,200 90,600 65,500 195,100 73,600 129,600 56,000 37,400 157,800 57,600 120,400 Gross profit 124,200 321,900 112,700 197,700 85,000 94,100 339,200 140,400 245,100 Operating expenses Research and development 27,800 82,900 26,600 55,100 28,500 26,200 82,000 27,700 55,800 Sales and marketing 43,400 123,800 41,100 80,400 39,300 38,100 129,800 45,500 91,700 General and administrative 46,300 144,500 48,400 98,200 49,800 67,100 240,000 71,300 172,900 117,500 351,200 116,100 233,700 117,600 131,400 451,800 144,500 320,400 Net income (loss) from operations 6,700 (29,300 ) (3,400 ) (36,000 ) (32,600 ) (37,300 ) (112,600 ) (4,100 ) (75,300 ) Other income (expenses) Reversal of accounts payable – – – – – – 7,800 2,200 7,800 Interest expense, bank charges, financing cost and accretion of interest (4,800 ) (10,700 ) (3,000 ) (5,900 ) (2,900 ) (3,300 ) (6,800 ) (1,800 ) (3,500 ) (4,800 ) (10,700 ) (3,000 ) (5,900 ) (2,900 ) (3,300 ) 1,000 400 4,300 Net income (loss) $ 1,900 $ (40,000 ) $ (6,400 ) $ (41,900 ) $ (35,500 ) $ (40,600 ) $ (111,600 ) $ (3,700 ) $ (71,000 ) Net income (loss) per common share Basic $ .00 $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) Diluted $ .00 $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) $ (.00 ) Weighted average common shares outstanding Basic 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,554,194 58,599,016 58,532,194 Diluted 58,745,139 58,599,016 58,599,016 58,599,016 58,599,016 58,599,016 58,554,194 58,599,016 58,532,194 Nocopi Technologies, Inc. Statements of Cash Flows (Unaudited) Nine Months Six Months Three Months ended ended ended September 30, June 30, March 31, 2014 2014 2014 Operating Activities Net loss $ (37,500 ) $ (15,100 ) $ (25,200 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities Depreciation and amortization 2,900 1,700 400 Accretion of interest - convertible debentures 3,400 2,100 1,000 (31,200 ) (11,300 ) (23,800 ) (Increase) decrease in assets Accounts receivable 51,800 (28,400 ) 38,900 Inventory (19,000 ) (1,400 ) (8,300 ) Prepaid and other 21,400 19,500 10,300 Increase (decrease) in liabilities Accounts payable and accrued expenses 26,300 3,500 1,200 Deferred revenue 9,300 7,000 (8,100 ) 89,800 200 34,000 Net cash provided by (used in) operating activities 58,600 (11,100 ) 10,200 Investment Activities Additions to fixed assets (20,000 ) (20,000 ) (20,000 ) Net cash used in investment activities (20,000 ) (20,000 ) (20,000 ) Financing Activities Repayment of borrowings under promissory note (18,800 ) (12,500 ) (6,300 ) Repayment of demand loans (5,000 ) – – Proceeds from convertible debenture 5,000 – – Net cash used in financing activities (18,800 ) (12,500 ) (6,300 ) 19,800 (43,600 ) (16,100 ) Cash at beginning of year 52,900 52,900 52,900 Cash at end of period 72,700 9,300 36,800 Supplemental Disclosure of Cash Flow Information Cash paid for interest $ 300 $ 300 $ 200 Supplemental Disclosure of Non Cash Investing Activities Write-off of fully depreciated leasehold improvements and furniture, fixtures and equipment Accumulated depreciation and amortization $ (82,900 ) $ (82,900 ) $ (82,900 ) Leasehold improvements $ 72,500 $ 72,500 $ 72,500 Furniture, fixtures and equipment $ 10,400 $ 10,400 $ 10,400 Supplemental Disclosure of Non Cash Financing Activities Conversion of demand loans and interest to convertible debentures Demand loans $ 24,500 – – Accrued expenses $ 3,800 – – Convertible debentures $ 26,400 – – Paid-in capital $ 1,900 – – Nocopi Technologies, Inc. Statements of Cash Flows (Unaudited) Nine Months Six Months Three Months Nine Months Six Months ended ended ended ended ended September 30, June 30, March 31, September 30, June 30, 2013 2013 2013 2012 2012 Operating Activities Net loss $ (40,000 ) $ (41,900 ) $ (35,500 ) $ (111,600 ) $ (71,000 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities Depreciation and amortization 600 600 300 2,700 1,800 Reversal of accounts payable – – – (7,800 ) (7,800 ) Financing cost – warrant grants 100 100 100 1,000 – Accretion of interest – convertible debentures 1,100 – – – – (38,200 ) (41,200 ) (35,100 ) (115,700 ) (77,000 ) (Increase) decrease in assets Accounts receivable (90,900 ) (85,100 ) (89,200 ) (46,100 ) (35,300 ) Inventory (3,000 ) (26,200 ) 15,700 (1,000 ) 5,700 Prepaid and other 12,400 10,000 6,700 10,800 5,800 Increase in liabilities Accounts payable and accrued expenses 39,900 66,300 42,700 101,100 24,500 Deferred revenue 87,600 88,500 43,000 10,200 64,300 46,000 53,500 18,900 75,000 65,000 Net cash provided by (used in) operating activities 7,800 12,300 (16,200 ) (40,700 ) (12,000 ) Financing Activities Repayment of borrowings under promissory note (18,800 ) (12,500 ) (6,300 ) (18,800 ) (12,500 ) Proceeds from demand loan 3,000 3,000 3,000 34,800 2,500 Repayment of demand loan – – – (2,500 ) (2,500 ) Proceeds from convertible debentures 105,000 – – – – Issuance of common stock – – – 10,000 10,000 Net cash provided by (used in) financing activities 89,200 (9,500 ) (3,300 ) 23,500 (2,500 ) Increase (decrease) in cash 97,000 2,800 (19,500 ) (17,200 ) (14,500 ) Cash at beginning of year 20,600 20,600 20,600 22,900 22,900 Cash at end of period $ 117,600 $ 23,400 $ 1,100 $ 5,700 $ 8,400 Supplemental Disclosure of Cash Flow Information Cash paid for interest $ 1,000 $ 700 $ 400 $ 1,700 $ 1,200 Supplemental disclosure of Non Cash Financing Activities Conversion of demand loan and interest to common stock Demand loans – – – $ 1,500 $ 1,500 Accrued expenses – – – $ 1,200 $ 1,200 Common stock – – – $ 400 $ 400 Paid-in capital – – – $ 2,300 $ 2,300

Significant Accounting Polici27

Significant Accounting Policies (Schedule of Basic and Diluted Weighted Average Common Shares Outstanding) (Details) - shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Basic shares outstanding	58,599,016	58,599,016	58,565,605
Incremental shares from assumed conversion of stock options and warrants	1,674	88,678
Diluted shares outstanding	58,600,690	58,687,694	58,565,605

Going Concern (Details)

Going Concern (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Class of Stock [Line Items]
Net loss (income)	$ (7,700)	$ (10,300)	$ 146,100
Accumulated deficit	13,432,700	13,440,400	13,450,700
Working capital deficit	424,500	350,600	467,200
Operating loss (income)	(29,000)	12,900	$ 143,800
Proceeds from convertible debentures	$ 5,000	105,000
Proceeds from demand loans		$ 3,000	$ 49,500
Common stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares			208,334
Proceeds from stock issued through private placement			$ 10,000

Concentration of Credit Risk (D

Concentration of Credit Risk (Details) None in scaling factor is -9223372036854775296	Dec. 31, 2014USD ($)
Risks and Uncertainties [Abstract]
Amount of cash unisured by FDIC

Demand Loans (Details)

Demand Loans (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Short-term Debt [Line Items]
Debt instrument, payment terms			Forty-eight equal monthly installments
Repayments of demand loans			$ 5,000		$ 2,500
Unsecured Loan [Member] | Unsecured Loan One [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 5,800
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Jul. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			5,800
Price per share of warrants			$ 0.06
Warrant expiration term			5 years
Financing cost from warrants charged to income		$ 200
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.64%
Fair value assumptions, historical volatility			108.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Two [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 3,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Jul. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			3,000
Price per share of warrants			$ 0.06
Warrant expiration term			5 years
Financing cost from warrants charged to income		100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.60%
Fair value assumptions, historical volatility			108.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Three [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 3,500
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Aug. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			3,500
Price per share of warrants			$ 0.07
Warrant expiration term			5 years
Financing cost from warrants charged to income		100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.61%
Fair value assumptions, historical volatility			108.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Four [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 20,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Sep. 30, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			20,000
Price per share of warrants			$ 0.03
Warrant expiration term			5 years
Financing cost from warrants charged to income		400
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.68%
Fair value assumptions, historical volatility			110.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Five [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 3,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Oct. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			3,000
Price per share of warrants			$ 0.03
Warrant expiration term			5 years
Financing cost from warrants charged to income		100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.67%
Fair value assumptions, historical volatility			113.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Six [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 3,700
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Oct. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			3,700
Price per share of warrants			$ 0.025
Warrant expiration term			5 years
Financing cost from warrants charged to income		100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.67%
Fair value assumptions, historical volatility			113.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Seven [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 4,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Oct. 31, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			4,000
Price per share of warrants			$ 0.022
Warrant expiration term			5 years
Financing cost from warrants charged to income		100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.82%
Fair value assumptions, historical volatility			113.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Eight [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 4,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Nov. 30, 2012
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			4,000
Price per share of warrants			$ .01
Warrant expiration term			5 years
Financing cost from warrants charged to income		$ 100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.73%
Fair value assumptions, historical volatility			113.00%
Fair value assumptions, dividend yield			0.00%
Unsecured Loan [Member] | Unsecured Loan Nine [Member]
Short-term Debt [Line Items]
Debt instrument, face amount			$ 3,000
Debt instrument, interest rate			8.00%
Debt instrument, issuance date			Mar. 31, 2013
Debt instrument, payment terms			Payable on demand
Number of shares of common stock that can be purchased through warrants			3,000
Price per share of warrants			$ 0.021
Warrant expiration term			5 years
Financing cost from warrants charged to income	$ 100
Pricing model used to value warrants			Black-Scholes pricing model
Fair value assumptions, expected term			5 years
Fair value assumption, interest rate			0.77%
Fair value assumptions, historical volatility			101.00%
Fair value assumptions, dividend yield			0.00%

Promissory Note (Details)

Promissory Note (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 31, 2014	Dec. 31, 2014	Dec. 31, 2009
Line of Credit Facility [Abstract]
Revolving line of credit, maximum borrowing capacity		$ 100,000
Revolving line of credit, interest rate		3.75%
Revolving line of credit, basis spread over prime rate		0.50%
Revolving line of credit, amount outstanding			$ 100,000
Amount of monthly installment payments of principal, plus interest to repay line of credit facility		$ 2,083
Re-payment terms of line of credit facility		Forty-eight equal monthly installments
Revolving line of credit, required first payment date		Oct. 1, 2010
Repayment of line of credit	$ 6,250

Convertible Debentures (Details

Convertible Debentures (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Interest expense		$ 21,600	$ 16,300	$ 10,100
Warrant [Member]
Debt Instrument [Line Items]
Fair value of warrants issued	$ 2,000	2,000
Relative fair value of warrants recorded as discount to notes payable	$ 1,900	1,900
Pricing model used to value warrants	Black-Scholes pricing model
Interest expense		500
Number of warrants issued during period	166,400
Convertible Debt [Member] | Convertible Debt One [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 105,000	$ 105,000
Debt instrument, issuance date		During third quarter 2013
Debt instrument, interest rate	7.00%	7.00%
Debt instrument, maturity date		Two years from date of issuance
Debt instrument, conversion price per share	$ .05	$ .05
Number of shares of common stock that can be purchased through warrants	525,000	525,000
Price per share of warrants	$ .02	$ .02
Warrant exercisable term		2 years
Warrant expiration term		7 years
Fair value of warrants issued	$ 9,100	$ 9,100
Relative fair value of warrants recorded as discount to notes payable	8,300	$ 8,300
Pricing model used to value warrants		Black-Scholes pricing model
Interest expense		$ 4,200	$ 2,100
Convertible Debt [Member] | Convertible Debt Two [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 28,300	$ 28,300
Debt instrument, issuance date		During third quarter 2014
Debt instrument, interest rate	7.00%	7.00%
Debt instrument, maturity date		Two years from date of issuance
Debt instrument, conversion price per share	$ 0.05	$ 0.05
Number of shares of common stock that can be purchased through warrants	141,400	141,400
Price per share of warrants	$ .02	$ .02
Warrant exercisable term		2 years
Warrant expiration term		7 years
Convertible Debt [Member] | Convertible Debt Three [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 5,000	$ 5,000
Debt instrument, issuance date		During third quarter 2014
Debt instrument, interest rate	7.00%	7.00%
Debt instrument, maturity date		Two years from date of issuance
Debt instrument, conversion price per share	$ .05	$ .05
Number of shares of common stock that can be purchased through warrants	25,000	25,000
Price per share of warrants	$ 0.02	$ 0.02
Warrant exercisable term		2 years
Warrant expiration term		7 years

Stockholders' Deficiency (Detai

Stockholders' Deficiency (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2012	Dec. 31, 2012	Mar. 16, 2012
Director [Member]
Class of Stock [Line Items]
Amount of principal on unsecured loan converted into restricted common stock per conversion agreement			$ 1,500
Amount of accrued interest on unsecured loan converted into restricted common stock per conversion agreement			1,200
Director [Member] | Unsecured Loan [Member]
Class of Stock [Line Items]
Debt instrument, carrying amount			$ 4,500
Common stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares		208,334
Proceeds from stock issued through private placement		$ 10,000
Restricted Common Stock [Member] | Director [Member]
Class of Stock [Line Items]
Shares of stock issued through Conversion Agreement	44,216
Share price			$ 0.06

Other Income (Expenses) (Detail

Other Income (Expenses) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Other Income and Expenses [Abstract]
Reversal of accounts payable		$ 39,500	$ 7,800

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating Loss Carryforwards [Line Items]
Income tax provision
Net operating loss carryforwards	$ 4,601,000	$ 5,079,000	$ 5,658,000
Deferred tax assets, valuation allowance	$ 1,933,000	$ 2,133,000	$ 2,377,000
Unrecognized tax benefits
Change in unrecognized tax benefits during the period
Accrual for uncertain tax positions
Interest and penalties from tax examinations recognized in the statement of operations
Interest and penalties from tax examinations recognized on the balance sheet
Minimum [Member]
Operating Loss Carryforwards [Line Items]
Tax years open for examination	2,011
Maximum [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards, expiration date	Dec. 31, 2034
Tax years open for examination	2,014

Commitments and Contingencies (

Commitments and Contingencies (Operating Leases) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Lease expiration date	Dec. 31, 2019
Future minimum payments due under operating leases:
2,015	$ 44,900
2,016	46,200
2,017	47,400
2,018	48,600
2,019	16,300
Total rent expense under operating lease agreement	$ 44,800	$ 44,200	$ 44,400

Commitments and Contingencies37

Commitments and Contingencies (Employment Agreements) (Details) - Dec. 31, 2014 - Employment Agreement [Member] - USD ($)	Total
Other Commitments [Line Items]
Future minimum compensation payments due 2015	$ 160,000
Future minimum compensation payments due 2016	$ 54,200
Chief Executive Officer [Member]
Other Commitments [Line Items]
Employment contract, expiration date	2016-05
Annual base compensation owed to employee per employment agreement	$ 85,000
Chief Operating Officer [Member]
Other Commitments [Line Items]
Employment contract, expiration date	2016-03
Annual base compensation owed to employee per employment agreement	$ 75,000
Commission rate owed to employee expressed as percentage of sales	7.00%

Stock Options, Warrants and 438

Stock Options, Warrants and 401(k) Savings Plan (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under plan	2,000,000
Method used to value the grant date fair value of awards	Black-Scholes option pricing model
Compensation expense from options not yet recognized
Shares remaining available for grant	0
Employer contributions for 401(k) savings plan charged to expense during period
Stock option compensation expense recognized
Number of common shares reserved for possible future warrant issuance and debt conversion	3,955,005
Value of outstanding convertible debentures and accrued interest that could be converted	$ 138,300
Number of common shares reserved for possible future debt conversion	3,152,640
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants expiration date	2021-07

Stock Options, Warrants and 439

Stock Options, Warrants and 401(k) Savings Plan (Summary of Stock Option Activity) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Number of Shares
Options outstanding at beginning of period	245,000	645,000	645,000
Options expired	245,000	400,000	0
Options outstanding at end of period	0	245,000	645,000
Options exercisable at end of period	0
Weighted Average Exercise Price
Options outstanding at beginning of period	$ 0.12	$ 0.32	$ 0.32
Options expired	$ 0.12	0.45
Options outstanding at end of period		$ 0.12	$ 0.32

Stock Options, Warrants and 440

Stock Options, Warrants and 401(k) Savings Plan (Summary of Warrants Activity) (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Warrants
Warrants outstanding at beginning of period	660,500	132,500	85,500
Granted	166,365	528,000	47,000
Cancelled	24,500
Warrants outstanding at end of period	802,365	660,500	132,500
Price
Warrants outstanding at beginning of period	$ 0.026	$ 0.052	$ 0.061
Granted	0.02	0.02	0.036
Cancelled	0.037
Warrants outstanding at end of period	$ 0.025	$ 0.026	$ 0.052

Stock Options and Warrants (Sum

Stock Options and Warrants (Summary of Warrants Outstanding by Price Range) (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share Based Compensation Shares Authorized Under Equity Instruments Other Than Options Exercise Price Range [Line Items]
Warrants outstanding exercise price range, lower limit	$ 0.01	$ 0.01	$ 0.01	$ 0.045
Warrants outstanding exercise price range, upper limit	0.07	0.07	0.07	$ 0.07
Warrants granted exercise price range, lower limit		0.02	0.01
Warrants granted exercise price range, upper limit	0.02	$ 0.021	$ 0.07
Warrants cancelled exercise price range, lower limit	0.03
Warrants cancelled exercise price range, upper limit	0.07
Warrants exercisable exercise price range, lower limit	0.01
Warrants exercisable exercise price range, upper limit	$ 0.07
Weighted average remaining contractual life	5 years 2 months 16 days
Number exercisable	111,000
Weighted average exercise price, exercisable	$ 0.055
Warrants exercisable, weighted average remaining contractual life	1 year 3 months 29 days

Major Customer and Geographic42

Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) - Revenue [Member]	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Customer A [Member]
Revenue, Major Customer [Line Items]
Risk percentage	47.00%	49.00%	14.00%
Customer B [Member]
Revenue, Major Customer [Line Items]
Risk percentage	19.00%	15.00%	10.00%

Major Customer and Geographic43

Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) - Accounts Receivable [Member]	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Customer A [Member]
Concentration Risk [Line Items]
Risk percentage	46.00%	45.00%	48.00%
Customer B [Member]
Concentration Risk [Line Items]
Risk percentage	35.00%	32.00%	20.00%

Major Customer and Geographic44

Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 922,800	$ 750,200	$ 637,000
North America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	477,100	365,700	540,600
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 445,700	$ 384,500	$ 96,400

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended	12 Months Ended			19 Months Ended
	Jul. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2015
Subsequent Event [Line Items]
Repayments of outstanding demand loans		$ 5,000		$ 2,500
Subsequent Event [Member]
Subsequent Event [Line Items]
Repayments of outstanding demand loans					$ 26,000
Repayments of convertible debenture	$ 10,000
Revised conversion price on $95,000 of convertible debentures	$ 0.025

Quarterly Financial Informati46

Quarterly Financial Information (Unaudited) (Balance Sheets) (Details) - USD ($)	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Dec. 31, 2011
Current assets
Cash	$ 28,000				$ 52,900				$ 20,600			$ 22,900
Accounts receivable less $5,000 allowance for doubtful accounts	287,800				237,100				68,500
Inventory	43,500				28,500				26,000
Prepaid and other	18,800				31,500				23,800
Total current assets	378,100				350,000				138,900
Fixed assets
Leasehold improvements	19,700				72,500				72,500
Furniture, fixtures and equipment	176,800				186,300				184,500
Fixed assets, gross	196,500				258,800				257,000
Less: accumulated depreciation and amortization	178,400				257,300				256,400
Total fixed assets	18,100				1,500				600
Total assets	$ 396,200				351,500				139,500
Current liabilities
Promissory note					18,800				43,800
Demand loans	$ 63,000				$ 92,500				$ 89,500
Convertible debentures	102,900
Accounts payable	160,300				$ 169,500				$ 245,600
Accrued expenses	383,000				306,000				201,200
Deferred revenue	93,400				113,800				26,000
Total current liabilities	$ 802,600				$ 700,600				$ 606,100
Commitments and contingencies
Convertible debentures, net of unaccreted discount of $1,400 at December 31, 2014 and $6,300 at December 31, 2013	$ 31,800				$ 98,700
Stockholders' deficiency
Series A preferred stock, $1.00 par value, Authorized - 300,000 shares, Issued and outstanding - none
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,599,016 shares	$ 586,000				$ 586,000				$ 586,000
Paid-in capital	12,408,500				12,406,600				12,398,100
Accumulated deficit	(13,432,700)				(13,440,400)				(13,450,700)
Total liabilities and stockholders' deficiency	$ 396,200				351,500				139,500
Quarterly Information [Member]
Current assets
Cash		$ 72,700	$ 9,300	$ 36,800	$ 52,900	$ 117,600	$ 23,400	$ 1,100	$ 20,600	$ 5,700	$ 8,400	$ 22,900
Accounts receivable less $5,000 allowance for doubtful accounts		185,300	265,500	198,200		159,400	153,600	157,700		77,900	67,100
Inventory		47,500	29,900	36,800		29,000	52,200	10,300		21,800	15,100
Prepaid and other		10,100	12,000	21,200		11,400	13,800	17,100		12,500	17,500
Total current assets		315,600	316,700	293,000		317,400	243,000	186,200		117,900	108,100
Fixed assets
Leasehold improvements		19,100	19,100	19,100		72,500	72,500	72,500		72,500	72,500
Furniture, fixtures and equipment		176,800	176,800	176,800		184,500	184,500	184,500		184,500	184,500
Fixed assets, gross		195,900	195,900	195,900		257,000	257,000	257,000		257,000	257,000
Less: accumulated depreciation and amortization		177,300	176,100	174,800		$ 257,000	$ 257,000	256,700		256,000	255,100
Total fixed assets		18,600	19,800	21,100				300		1,000	1,900
Total assets		$ 334,200	336,500	314,100		$ 317,400	$ 243,000	186,500		118,900	110,000
Current liabilities
Promissory note			6,300	12,500		25,000	31,300	37,500		50,000	56,300
Demand loans		$ 63,000	$ 92,500	$ 92,500		$ 92,500	$ 92,500	$ 92,500		$ 74,800	$ 42,500
Convertible debentures		101,900
Accounts payable		135,200	$ 130,400	$ 147,200		$ 195,200	$ 235,500	$ 253,000		$ 215,400	$ 192,600
Accrued expenses		362,800	348,600	329,500		291,500	277,600	236,500		158,000	104,200
Deferred revenue		123,100	120,800	105,700		113,600	114,500	69,000		53,000	107,100
Total current liabilities		786,000	698,600	687,400		717,800	$ 751,400	$ 688,500		$ 551,200	$ 502,700
Convertible debentures, net of unaccreted discount of $1,400 at December 31, 2014 and $6,300 at December 31, 2013		31,600	100,800	99,700		97,700
Stockholders' deficiency
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,599,016 shares		586,000	586,000	586,000		586,000	$ 586,000	$ 586,000		$ 586,000	$ 586,000
Paid-in capital		12,408,500	12,406,600	12,406,600		12,406,600	12,398,200	12,398,200		12,397,900	12,396,900
Accumulated deficit		(13,477,900)	(13,455,500)	(13,465,600)		(13,490,700)	(13,492,600)	(13,486,200)		(13,416,200)	(13,375,600)
Total stockholders' deficiency		(483,400)	(462,900)	(473,000)		(498,100)	(508,400)	(502,000)		(432,300)	(392,700)
Total liabilities and stockholders' deficiency		$ 334,200	$ 336,500	$ 314,100		$ 317,400	$ 243,000	$ 186,500		$ 118,900	$ 110,000

Quarterly Financial Informati47

Quarterly Financial Information (Unaudited) (Statements of Operations) (Details) - USD ($)	3 Months Ended								6 Months Ended			9 Months Ended			12 Months Ended
	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues
Licenses, royalties and fees															$ 358,800	$ 295,100	$ 414,900
Product and other sales															564,000	455,100	222,100
Total revenues															922,800	750,200	637,000
Cost of revenues
Licenses, royalties and fees															75,600	67,200	52,500
Product and other sales															248,700	218,300	149,500
Total cost of revenues															324,300	285,500	202,000
Gross profit															598,500	464,700	435,000
Operating expenses
Research and development															121,600	111,900	109,400
Sales and marketing															194,500	170,500	167,400
General and administrative															253,400	195,200	302,000
Total operating expenses															569,500	477,600	578,800
Net income (loss) from operations															$ 29,000	(12,900)	(143,800)
Other income (expenses)
Reversal of accounts payable																$ 39,500	$ 7,800
Interest income															$ 300
Interest expense, bank charges, financing cost and accretion of interest															(21,600)	$ (16,300)	$ (10,100)
Total other income (expenses)															(21,300)	23,200	(2,300)
Net income (loss)															$ 7,700	$ 10,300	$ (146,100)
Net income (loss) per common share
Basic															$ 0	$ 0	$ 0
Diluted															$ 0	$ 0	$ 0
Weighted average common shares outstanding
Basic															58,599,016	58,599,016	58,565,605
Diluted															58,600,690	58,687,694	58,565,605
Quarterly Information [Member]
Revenues
Licenses, royalties and fees	$ 83,000	$ 77,500	$ 80,000	$ 82,800	$ 69,900	$ 57,100	$ 107,700	$ 112,800	$ 157,500	$ 127,000	$ 216,900	$ 240,500	$ 209,800	$ 324,600
Product and other sales	125,800	158,600	104,900	106,900	116,400	83,900	23,800	85,200	263,500	200,300	148,600	389,300	307,200	172,400
Total revenues	208,800	236,100	184,900	189,700	186,300	141,000	131,500	198,000	421,000	327,300	365,500	629,800	517,000	497,000
Cost of revenues
Licenses, royalties and fees	17,700	19,300	17,200	15,100	17,400	14,100	10,400	14,400	36,500	31,500	29,800	54,200	46,600	40,200
Product and other sales	56,000	65,200	55,300	50,400	56,200	41,900	27,000	43,200	120,500	98,100	90,600	176,500	148,500	117,600
Total cost of revenues	73,700	84,500	72,500	65,500	73,600	56,000	37,400	57,600	157,000	129,600	120,400	230,700	195,100	157,800
Gross profit	135,100	151,600	112,400	124,200	112,700	85,000	94,100	140,400	264,000	197,700	245,100	399,100	321,900	339,200
Operating expenses
Research and development	29,200	30,400	30,600	27,800	26,600	28,500	26,200	27,700	61,000	55,100	55,800	90,200	82,900	82,000
Sales and marketing	46,800	46,600	47,600	43,400	41,100	39,300	38,100	45,500	94,200	80,400	91,700	141,000	123,800	129,800
General and administrative	75,900	59,200	54,400	46,300	48,400	49,800	67,100	71,300	113,600	98,200	172,900	189,500	144,500	240,000
Total operating expenses	151,900	136,200	132,600	117,500	116,100	117,600	131,400	144,500	268,800	233,700	320,400	420,700	351,200	451,800
Net income (loss) from operations	$ (16,800)	$ 15,400	$ (20,200)	$ 6,700	$ (3,400)	$ (32,600)	$ (37,300)	(4,100)	$ (4,800)	$ (36,000)	(75,300)	$ (21,600)	$ (29,300)	(112,600)
Other income (expenses)
Reversal of accounts payable								$ 2,200			$ 7,800			$ 7,800
Interest income			$ 300						$ 300			$ 300
Interest expense, bank charges, financing cost and accretion of interest	$ (5,600)	$ (5,300)	(5,300)	$ (4,800)	$ (3,000)	$ (2,900)	$ (3,300)	$ (1,800)	(10,600)	$ (5,900)	$ (3,500)	(16,200)	$ (10,700)	$ (6,800)
Total other income (expenses)	(5,600)	(5,300)	(5,000)	(4,800)	(3,000)	(2,900)	(3,300)	400	(10,300)	(5,900)	4,300	(15,900)	(10,700)	1,000
Net income (loss)	$ (22,400)	$ 10,100	$ (25,200)	$ 1,900	$ (6,400)	$ (35,500)	$ (40,600)	$ (3,700)	$ (15,100)	$ (41,900)	$ (71,000)	$ (37,500)	$ (40,000)	$ (111,600)
Basic and diluted loss per common share	$ 0	$ 0	$ 0						$ 0			$ 0
Net income (loss) per common share
Basic				$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0		$ 0	$ 0
Diluted				$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0		$ 0	$ 0
Weighted average common shares outstanding
Basic	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,532,194	58,599,016	58,599,016	58,554,197
Diluted	58,599,016	58,600,830	58,599,016	58,745,139	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,599,016	58,532,194	58,599,016	58,599,016	58,554,197

Quarterly Financial Informati48

Quarterly Financial Information (Unaudited) (Statements of Cash Flows) (Details) - USD ($)	3 Months Ended								6 Months Ended			9 Months Ended			12 Months Ended
	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating Activities
Net income (loss)															$ 7,700	$ 10,300	$ (146,100)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization															$ 4,000	900	3,100
Reversal of accounts payable																(39,500)	(7,800)
Financing cost - warrant grants																100	$ 1,200
Accretion of interest - convertible debentures															$ 4,600	2,100
Net income (loss) adjusted for non-cash operating activities															16,300	(26,100)	$ (149,600)
(Increase) decrease in assets
Accounts receivable															(50,700)	(168,600)	(36,700)
Inventory															(15,000)	(2,500)	(5,200)
Prepaid and other															12,700	(7,700)	(500)
Increase (decrease) in liabilities
Accounts payable and accrued expenses															71,600	68,200	174,500
Deferred revenue															(20,400)	87,800	(16,800)
Total increase (decrease) in operating capital															(1,800)	(22,800)	115,300
Net cash provided by (used in) operating activities															14,500	(48,900)	$ (34,300)
Investing Activities
Additions to fixed assets															(20,600)	(1,800)
Net cash used in investing activities															(20,600)	(1,800)
Financing Activities
Repayment of borrowings under promissory note															$ (18,800)	(25,000)	$ (25,000)
Proceeds from demand loans																$ 3,000	49,500
Repayment of demand loan															$ (5,000)		$ (2,500)
Proceeds from convertible debentures															$ 5,000	$ 105,000
Issuance of common stock																	$ 10,000
Net cash provided by (used in) financing activities															$ (18,800)	$ 83,000	32,000
Increase (decrease) in cash															(24,900)	32,300	(2,300)
Cash
Beginning of year			$ 52,900			$ 20,600			$ 52,900	$ 20,600	$ 22,900	$ 52,900	$ 20,600	$ 22,900	52,900	20,600	22,900
End of year															28,000	52,900	20,600
Supplemental Disclosure of Cash Flow Information
Cash paid for interest															300	$ 1,200	$ 2,200
Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment
Accumulated depreciation and amortization															(82,900)
Leasehold improvements															72,500
Furniture, fixtures and equipment															10,400
Conversion of demand loans and interest to convertible debentures
Demand loans															24,500
Accrued expenses															3,800
Convertible debentures															26,400
Paid-in capital															$ 1,900
Conversion of demand loans and interest to common stock
Demand loans																	$ 1,500
Accrued expenses																	1,200
Common stock																	400
Paid-in capital																	2,300
Quarterly Information [Member]
Operating Activities
Net income (loss)	$ (22,400)	$ 10,100	(25,200)	$ 1,900	$ (6,400)	(35,500)	$ (40,600)	$ (3,700)	(15,100)	(41,900)	(71,000)	(37,500)	(40,000)	(111,600)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization			$ 400			$ 300			$ 1,700	$ 600	1,800	$ 2,900	$ 600	2,700
Reversal of accounts payable								(2,200)			$ (7,800)			(7,800)
Financing cost - warrant grants						$ 100				$ 100			$ 100	$ 1,000
Accretion of interest - convertible debentures			$ 1,000						$ 2,100			$ 3,400	1,100
Net income (loss) adjusted for non-cash operating activities			(23,800)			$ (35,100)			(11,300)	$ (41,200)	$ (77,000)	(31,200)	(38,200)	$ (115,700)
(Increase) decrease in assets
Accounts receivable			38,900			(89,200)			(28,400)	(85,100)	(35,300)	51,800	(90,900)	(46,100)
Inventory			(8,300)			15,700			(1,400)	(26,200)	5,700	(19,000)	(3,000)	(1,000)
Prepaid and other			10,300			6,700			19,500	10,000	5,800	21,400	12,400	10,800
Increase (decrease) in liabilities
Accounts payable and accrued expenses			1,200			42,700			3,500	66,300	24,500	26,300	39,900	101,100
Deferred revenue			(8,100)			43,000			7,000	88,500	64,300	9,300	87,600	10,200
Total increase (decrease) in operating capital			34,000			18,900			200	53,500	65,000	89,800	46,000	75,000
Net cash provided by (used in) operating activities			10,200			(16,200)			(11,100)	12,300	(12,000)	58,600	7,800	(40,700)
Investing Activities
Additions to fixed assets			(20,000)						(20,000)			(20,000)
Net cash used in investing activities			(20,000)						(20,000)			(20,000)
Financing Activities
Repayment of borrowings under promissory note			$ (6,300)			(6,300)			$ (12,500)	(12,500)	(12,500)	$ (18,800)	(18,800)	(18,800)
Proceeds from demand loans						$ 3,000				$ 3,000	2,500		$ 3,000	34,800
Repayment of demand loan											$ (2,500)	$ (5,000)		$ (2,500)
Proceeds from convertible debentures												$ 5,000	$ 105,000
Issuance of common stock											$ 10,000			$ 10,000
Net cash provided by (used in) financing activities			$ (6,300)			$ (3,300)			$ (12,500)	$ (9,500)	(2,500)	$ (18,800)	$ 89,200	23,500
Increase (decrease) in cash			(16,100)			(19,500)			(43,600)	2,800	(14,500)	19,800	97,000	(17,200)
Cash
Beginning of year	$ 9,300	$ 36,800	52,900	$ 23,400	$ 1,100	20,600	$ 8,400		52,900	20,600	22,900	52,900	20,600	22,900	$ 52,900	$ 20,600	22,900
End of year	$ 72,700	$ 9,300	36,800	$ 117,600	$ 23,400	1,100	$ 5,700	$ 8,400	9,300	23,400	8,400	72,700	117,600	5,700		$ 52,900	$ 20,600
Supplemental Disclosure of Cash Flow Information
Cash paid for interest			200			$ 400			300	$ 700	1,200	300	$ 1,000	1,700
Write-off of fully depreciated leasehold improvements and furniture fixtures and equipment
Accumulated depreciation and amortization			(82,900)						(82,900)			(82,900)
Leasehold improvements			72,500						72,500			72,500
Furniture, fixtures and equipment			$ 10,400						$ 10,400			10,400
Conversion of demand loans and interest to convertible debentures
Demand loans												24,500
Accrued expenses												3,800
Convertible debentures												26,400
Paid-in capital												$ 1,900
Conversion of demand loans and interest to common stock
Demand loans											1,500			1,500
Accrued expenses											1,200			1,200
Common stock											400			400
Paid-in capital											$ 2,300			$ 2,300